Purdue

Supreme Court to Deliver Landmark Ruling in Purdue Pharma Bankruptcy, A Potent Closure to an Opioid Saga

by

Washington, D.C. — The United States Supreme Court is poised to deliver its decision on the bankruptcy case of Purdue Pharma LP, marking a significant milestone in the ongoing battle against the opioid epidemic, a crisis responsible for over 750,000 deaths between 1999 and 2022. This forthcoming opinion is expected to address numerous legal and ethical issues surrounding one of the most notorious pharmaceutical giants in recent history. Purdue Pharma, widely criticized for its role in the opioid crisis, sought bankruptcy protection to manage the wave of lawsuits alleging it aggressively marketed OxyContin despite knowing … Read more

Supreme Court’s Decision on Purdue Pharma Sets Potential Precedent for Future Mass Tort Settlements

by

Washington, D.C. – A recent Supreme Court decision affirming the opioid settlement by Purdue Pharma could set significant precedents for how similar mass tort cases are resolved in the future. The ruling, which supports the pharmaceutical giant’s plan to restructure under bankruptcy protection, encompasses a multi-billion dollar agreement pivotal for communities affected by the opioid epidemic. The contentious approval by the Supreme Court has confirmed Purdue Pharma’s settlement plan, estimated at over $10 billion, which aims to mitigate the public health crisis tied to opioids. This decision not only impacts those directly involved in the … Read more

Purdue Pharma Faces Intense Scrutiny as Bankruptcy Trustees Navigate Complex Mass Tort Litigation

by

Stamford, Conn.— Purdue Pharma, the company widely criticized for its role in the opioid crisis, has reached a critical juncture in its Chapter 11 bankruptcy proceedings that could significantly impact the landscape of mass tort litigation in the United States. Facing thousands of lawsuits, the pharmaceutical giant filed for bankruptcy in 2019 as part of an effort to settle claims alleging it fueled a national addiction epidemic with its aggressive marketing of the painkiller OxyContin. The latest proposal in Purdue Pharma’s bankruptcy case, which aims to resolve multitudes of opioid lawsuits, stipulates that the Sackler … Read more

Supreme Court Set to Deliver Landmark Verdict on Purdue Pharma Bankruptcy Amid Opioid Epidemic

by

Washington, D.C. – A pivotal decision is expected from the U.S. Supreme Court regarding the bankruptcy case of Purdue Pharma LP, as the nation continues grappling with an opioid crisis that has claimed over 750,000 lives to date. This ruling could herald a significant development in addressing the ramifications of one of the deadliest health emergencies in American history. Purdue Pharma, the maker of OxyContin, has been at the epicenter of lawsuits and public outcry, with numerous claims that the company aggressively marketed its highly addictive painkiller without proper warnings of its potential for abuse. … Read more